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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease manifested by
progressive muscle atrophy and paralysis due to the loss of upper and lower motoneurons
(MN). Spasticity appears in ALS patients leading to further disabling consequences. Loss
of the inhibitory tone induced by downregulation of the potassium chloride cotransporter
2 (KCC2) in MN has been proposed to importantly contribute to the spastic behavior after
spinal cord injury (SCI). The aim of the present study was to test whether the alterations
in the expression of KCC2 are linked to the appearance of spasticity in the SODG93A ALS
murine model. We compared SODG93A mice to wild type mice subjected to SCI to mimic
the spinal MN disconnection from motor descending pathways, and to sciatic nerve lesion
to mimic the loss of MN connectivity to muscle. Electrophysiological results show that
loss of motor function is observed at presymptomatic stage (8 weeks) in SODG93A mice
but hyperreflexia and spasticity do not appear until a late stage (16 weeks). However, KCC2
was not downregulated despite MN suffered disconnection both from muscles and upper
MNs. Further experiments revealed decreased gephyrin expression, as a general marker of
inhibitory systems, accompanied by a reduction in the number of Renshaw interneurons.
Moreover, 5-HT fibers were increased in the ventral horn of the lumbar spinal cord at
late stage of disease progression in SOD1G93A mice. Taken together, the present results
indicate that spasticity appears late in the ALS model, and may be mediated by a decrease
in inhibitory interneurons and an increase of 5-HT transmission, while the absence of
down-regulation of KCC2 could rather indicate an inability of MNs to respond to insults.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is an adult onset neurode-
generative disorder that clinically manifests by progressive muscle
atrophy and paralysis (Wijesekera and Leigh, 2009) due to the
loss of upper and lower motoneurons (MN). The 90% of ALS
cases are sporadic with unknown etiology whereas the remaining
10% are inherited forms, caused by genetic mutations. Among
these, mutations in the gene encoding for the enzyme Cu/Zn
superoxide dismutase 1 (SOD1) have been reported in about 20%
of the patients (Rosen, 1993). Several transgenic animal mod-
els of ALS have been developed during the last decades. The
most widely used is a transgenic mouse that over-expresses the
human mutated form of the sod1 gene with a glycine to alanine
conversion at the 93rd codon (Ripps et al., 1995). This model
recapitulates most relevant clinical and histopathological features
of both familial and sporadic forms of the human disease (Ripps
et al., 1995). Moreover, it has been recently reported that alter-
ations of SOD1 protein are also present in sporadic ALS cases,
increasing the interest of this model (Bosco et al., 2010).
Spasticity is a secondary complication of different upper MN
syndromes characterized by a velocity-dependent increase in
muscle tone resulting from hyperexcitability of the stretch reflex
(Lance, 1980). This phenomenon is present in ALS patients and
leads to important disabling complications that compromise their
manual dexterity and gait (Wijesekera and Leigh, 2009; Kiernan
et al., 2011). It has been hypothesized that spasticity may occur
due to the loss of upper MN and/or alterations of intraspinal
motor circuitry (Schütz, 2005; Chang and Martin, 2009, 2011;
Dentel et al., 2013). The appearance of spasticity has also been
described in the SOD1 ALS murine model (Dentel et al., 2013).
In fact, despite the remaining hindlimb muscle innervation at the
end stage of the disease could be enough to allow movement, the
animals appear paralyzed due to spastic paresis (Mancuso et al.,
2011).
Recent studies have demonstrated the relevance of MN
increased excitability for the appearance of spasticity after trau-
matic injuries to the spinal cord (Lu et al., 2008; Boulenguez et al.,
2010; Kakinohana et al., 2012; Bos et al., 2013). Rather than be
mediated by an increase in excitatory transmission, these studies
postulated that the loss of the inhibitory tone below the lesion is
mediated by downregulation of the potassium chloride cotrans-
porter 2 (KCC2) in spinal MNs (Boulenguez et al., 2010; Bos
et al., 2013). Modulation of the inhibitory amino acids (GABA
and glycine) response is determined by changes in the intracel-
lular chloride concentration [Cl−i ]. KCC2 is the main chloride
extruder expressed in adult neurons, being responsible for the
maintenance of the low [Cl−i ] (Ganguly et al., 2001; Rivera et al.,
2002; Wang et al., 2002; Payne et al., 2003; Stein et al., 2004;
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Bray and Mynlieff, 2009). At birth, when GABA and glycine
responses are excitatory (Ben-Ari et al., 2007), KCC2 is barely
detectable but increases progressively during the early post-natal
days of the murine life (Rivera et al., 1999; Wang et al., 2002;
Payne et al., 2003). Although excitatory actions of GABA and
glycine during early development are relevant for the establish-
ment of circuitry in the spinal cord and the development of motor
functional patterns (Stil et al., 2011), the increased excitability
induced by KCC2 down regulation in the adult spinal cord after
trauma has also been linked to alterations of locomotor pattern,
chronic pain and spasticity (Boulenguez et al., 2010; Bos et al.,
2013).
In the present experiment, we tested whether changes in the
expression of KCC2 in the SODG93A ALS model are of relevance
for the appearance of spasticity at late stages of the disease process.
For assessing the potential contributing mechanisms we com-
pared the changes in KCC2 induced by SCI and by peripheral
nerve lesions in wild type mice.
MATERIAL AND METHODS
TRANSGENIC SOD1G93A MICE
Transgenic mice with the G93A human SOD1 mutation
[B6SJL-Tg(SOD1-G93A)1Gur] were obtained from the Jackson
Laboratory (Bar Harbor, ME, USA), and maintained at the
Animal Service of the Universidad de Zaragoza. Hemizygotes
B6SJL SOD1G93A males were obtained by crossing with B6SJL
females from the CBATEG (Bellaterra, Spain). The offspring was
identified by PCR amplification of DNA extracted from the tail
tissue. All experimental procedures were approved by the Ethics
Committee of the Universitat Autònoma de Barcelona, where the
animal experiments were performed, and followed the guidelines
of the European Commission on Animal Care and the Canadian
Council on Animal Care.
SURGICAL PROCEDURES
Adult (8–10 weeks old) female wild type C57BL/6 mice (Charles
River) were anesthetized by i.p. injection of ketamine (10mg/kg;
Imalgene) and xylazine (1mg/kg; Rompun). For the nerve crush,
the sciatic nerve was exposed at the mid-thigh and subjected to
a crush during 30 s for three times in succession with a Dumont
no. 5 forceps. For SCI a laminectomy at the 11th thoracic ver-
tebra was performed. The exposed spinal cord was contused
using the Infinite Horizon Impactor device (Precision Scientific
Instrumentation), using a force of 50 kdynes and with tissue dis-
placement ranging between 500 and 700µm. After injury, the
skin was sutured and animals were left to recover on a hot pad
and returned to their home cages with free access to food and
water.
FUNCTIONAL ASSESSMENT
Locomotors recovery was evaluated in an open-field test using
the nine-point Basso Mouse Scale (BMS) (Basso et al., 2006;
Klopstein et al., 2012), which was specifically developed for loco-
motors testing after spinal cord contusion injuries in mice. The
BMS analysis of hindlimb movements and coordination was per-
formed by two independent researchers and the consensus score
was taken. The final score is presented as mean ± s.e.m.
NERVE CONDUCTION TESTS
The sciatic nerve was stimulated percutaneously by means of sin-
gle pulses of 0.02ms duration (Grass S88) delivered through a
pair of needle electrodes placed at the sciatic notch. The com-
pound muscle action potential (CMAP,M wave) and the reflex H
wave were recorded from the tibial anterior (TA) and the plantar
(interpose) muscles with microneedle electrodes (Valero-Cabré
and Navarro, 2001; Mancuso et al., 2011). For evaluation of the
motor central pathways, motor evoked potentials (MEP) were
recorded from the same muscles in response to transcranial elec-
trical stimulation of the motor cortex by single rectangular pulses
of 0.1ms duration, delivered through needle electrodes inserted
subcutaneously, the cathode over the skull overlaying the sensori-
motor cortex and the anode at the nose (García-Alías et al., 2003;
Mancuso et al., 2011). All potentials were amplified and displayed
on a digital oscilloscope (Tektronix 450S) at settings appropriate
to measure the amplitude from baseline to the maximal nega-
tive peak. To ensure reproducibility, the recording needles were
placed under microscope to secure the same placement on all ani-
mals guided by anatomical landmarks. During the tests, the mice
body temperature was kept constant by means of a thermostated
heating pad.
HISTOLOGY
SODG93A mice at 8, 12 and 16 weeks of age, and sciatic nerve
crushed (at 7 days post injury, dpi) and spinal cord injured (at
28 dpi) wild type mice were included in the histological analy-
sis (4–5 mice per group). Animals were transcardially perused
with 4% paraformaldehyde in PBS and the lumbar segment of
the spinal cord was harvested, post-fixed overnight, and cryop-
reserved in 30% sucrose. Transverse 40-µm thick sections were
serially cut with a cry tome (Lexica) between L2 and L5 segmental
levels. Spinal cord slices were sequentially collected free-floating
in Olmos medium.
For immunohistochemistry, sections were blocked with PBS-
Triton 0.3%-normal donkey serum 5% and incubated overnight
at 4◦C with primary antibodies: rabbit anti-KCC2 (KCC2, 1:500,
Millipore), mouse anti-neurofilament non-phosphorylated heavy
chain (SMI-32, 1:1000, Covance), mouse anti-activating tran-
scription factor 3 (ATF3, 1:500, Abeam), rabbit anti-ionized
calcium binding adaptor molecule 1 (Iba1, 1:1000, Wako), rab-
bit anti-serotonin (5-HT, 1:5000, Sigma) or rabbit anti-calbindin
(1:200, Chemicon). After washes, sections were incubated for 1 h
at room temperature with Alexi 488 or Alexi 594 conjugated sec-
ondary antibody (1:200; Life Science). For co-localization, spinal
NMS were labeled with NeuroTrace 500/525 Green Fluorescent
Nissl (1:200, Life Science).
To quantify microglial immunoreactivity, microphotographs
of the ventral horn gray matter were taken at ×400 and, after
defining the threshold for background correction, the integrated
density of Iba1 labeling was measured using ImageJ software
(Mancuso et al., 2012). The integrated density is the area above
the threshold for the mean density minus the background.
PROTEIN EXTRACTION ANDWESTERN BLOT
For protein extraction, another subset of mice (n = 3–4) of the
same experimental groups, i.e., SODG93A mice at 8, 12 or 16
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weeks of age, mice with sciatic nerve crush and mice with SCI,
were anesthetized and decapitated. The lumbar spinal cord was
removed and divided into quarters to isolate the ventral quad-
rants. In animals that received a sciatic nerve crush, only the
ventral horn of the lesioned side was used for protein extraction.
Samples were prepared for protein extraction and homogenized
in modified RIPA buffer (50 mom Tris–HCl pH 7.5, 1% Triton X-
100, 0.5% sodium deoxycholate, 0.2% SDS, 100mMNaCl, 1mM
EDTA) adding 10µl/ml of Protease Inhibitor cocktail (Sigma)
and PhosphoSTOP phosphatase inhibitor cocktail (Roche). After
clearance, protein concentration was measured by Lowry assay
(Bio-Rad, Dc protein assay).
Western blots were performed by loading 20µg of pro-
tein of each sample in SDS-poliacrylamide gels. The trans-
fer buffer was 25mM trizma-base, 192mM glycine, 20% (v/v)
methanol, pH 8.4. The membranes were blocked with 5% BSA
in PBS plus 0.1% Tween-20 for 1 h, and then incubated with
primary antibodies at 4◦C overnight. The primary antibod-
ies used were: mouse anti-GAPDH (1:20000, Millipore), rab-
bit anti-phospho-Ser940 KCC2 (1:1000, Phosphosolutions), rabbit
anti-KCC2 (1:500, Millipore), mouse anti-gephyrin (1:1000, BD
Bioscience) and anti-GAD65/67 (1:1000, Abcam). Horseradish
peroxidase–coupled secondary antibody (1:5000, Vector) incuba-
tion was performed for 1 h at room temperature. The membranes
were visualized using enhanced chemiluminiscence method and
the images were collected and analyzed with a Gene Genome
apparatus and Gene Snap and Gene Tools software (Signee),
respectively.
STATISTICAL ANALYSIS
Data are expressed as mean ± s.e.m. Electrophysiological test
results were statistically analyzed using repeated measurements
and One-Way ANOVA, applying Turkey post-hoc test when nec-
essary. For immunobloting and histological data we used Mann-
Whitney (for two groups comparison) or Kruskal-Wallis tests (for
multiple groups comparison) followed by Dunn’s post-hoc test
(Prism 6 software; Graphpad). The level of significance was set
at p < 0.05.
RESULTS
SOD1G93A ANIMALS SHOW HYPERREFLEXIA AND SPASTICITY AT
LATE STAGES OF DISEASE PROGRESSION
We first evaluated peripheral motor nerve conduction to assess
the progressive muscle denervation by stimulating the sciatic
nerve and recording in TA and plantar muscles (Mancuso et al.,
2011). Results revealed a different pattern of muscle denerva-
tion in the two tested muscles; the plantar muscle CMAP showed
a fast drop in amplitude at 12 weeks of age, whereas the TA
CMAP progressively decreased in amplitude from 8 weeks of age
(Figure 1A). The monosynaptic spinal reflex activity was assessed
by the H/M ratio (Mancuso et al., 2011). Results evidenced a sig-
nificant increase of the H/M ratio in both tested muscles (p <
0.01) at the end stage of the disease (16 weeks), coincident with
the spastic condition (Figure 1A). Figure 1B shows representa-
tive recordings to illustrate the increased H/M ratio in the plantar
muscle of 16 weeks aged SOD1G93A mice. Finally, we assessed cen-
tral motor conduction by means of MEPs to evaluate the state of
the spinal motor descending pathways. Results showed a signifi-
cant reduction of MEPs amplitude from 12 weeks of age both in
TA and plantar muscles (Figure 1A).
SPINAL CORD INJURY CAUSES LOCOMOTOR IMPAIRMENT AND
HYPERREFLEXIA
We evaluated the locomotor function of wild type mice after SCI
by means of the BMS score (Basso et al., 2006; Klopstein et al.,
2012). Results revealed that injured mice achieved less than 3
over the 9 points scale at 28 days, evidencing the inability to
support their own weight (Figure 1C). Then, we assessed central
motor conduction preservation and hyperreflexia of the animals
at 28 dpi. Results showed a significant reduction of MEPs and an
increased H/M ratio, coincident with the spastic behavior in the
animals’ hindlimbs (Figure 1C).
KCC2 EXPRESSION IS NOT ALTERED IN LUMBAR SPINAL MNs OF
SOD1G93A ANIMALS
We did not observe changes in the KCC2 oligomer/monomer
ratio (Figures 2A,B) in SOD1G93A mice at 8, 12, or 16 weeks
of age compared to wild type mice. Accordingly, no significant
changes in the phosphorylated form were observed in SOD1G93A
mice (Figures 2A,B). We then characterized the localization of
KCC2 by immunohistochemistry in lumbar MNs of SOD1G93A
mice along disease progression. Confocal images showed no
changes in subcellular localization of KCC2 at 8, 12 and 16 weeks
of age (Figure 2C). In fact, co-labeling of KCC2 and SMI-32 con-
firmed that KCC2 remained in the MNs plasma membrane at late
stages of the disease, as no co-localization of both markers was
observed in the samples of SOD1G93A mice, even in degenerat-
ing MNs (Figure 3). Taken together, these findings indicate that
KCC2 expression and localization in the MN plasma membrane
remains unchanged during ALS disease progression.
REDUCED ACTIVE FORM OF KCC2 IN LUMBAR SPINAL MNs AFTER SCI
We first examined KCC2 expression by western blotting in the
lumbar ventral spinal cord of animals with SCI at 28 dpi.
Compared to naïve animals, we observed a slight reduction of
total KCC2 after SCI (around 20%), although the difference
did not reach statistical significance (p = 0.06, data not shown).
This tendency is in agreement with previously reported results
by. Boulenguez et al. (2010) after SCI in the rat. To check the
activation state of the KCC2, we also performed western blot-
ting for the phosphorylated form of the KCC2 (pKCC2) with
a specific antibody against phopho-Ser940. In contrast to total
KCC2 expression, the phosphorylated form was decreased after
SCI compared to control samples (p < 0.05; Figures 4A,B). Since
it has been previously described that KCC2 oligomer/monomer
ratio is increased at maturity and correlates with KCC2 activa-
tion (Blaesse et al., 2006; Boulenguez et al., 2010; Bos et al.,
2013), we also analyzed the ratio between the oligomeric and
monomeric states of the KCC2. The results showed a signifi-
cant reduction of the oligomer/monomer ratio (Figures 4A,B;
p < 0.05), confirming the above results on the reduction of the
pKCC2 expression.
Confocal immunohistochemical images confirmed KCC2
staining into theMNs cytoplasm. This labeling pattern contrasted
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FIGURE 1 | (A,B) Peripheral and central motor conduction along disease
progression in SOD1G93A mice. (A) Plantar (upper) and tibialis anterior
(lower) compound muscle action potential (CMAP) amplitude, %H/M ratio
and motor evoked potentials (MEP) amplitudes of SOD1G93A animals at
8, 12, and 16 weeks of age. Values are represented as mean ± s.e.m.
Dashed line represents wild type mean value for each parameter.
∗p < 0.05; ∗∗p < 0.01 vs. wild type littermates. (B) Representative
recordings of plantar muscle CMAPs. Note the relative increase of the H
wave (arrow) reflecting hyperreflexia. Scale bars: 2mV; 2ms. (C)
Functional assessment of SCI animals. Compound muscle action potential
(CMAP) amplitude of the plantar muscle. Hyperreflexia evaluated by
means of the %H/M ratio recorded in the plantar muscle after sciatic
nerve stimulation. ∗p < 0.05 vs. naïve mice. The lack of differences
indicates that the increased %H/M ratio is not due to CMAP alterations.
Motor evoked potentials (MEP) amplitude. BMS score as a measure of
the locomotor capacity of the animals in the open field walking test.
Note that at 28 dpi the score remains below 3, indicating that animals
cannot support their own weight.
to the uniform band surrounding MNs in naïve animals
(Figure 4C). Together, these results indicate that the translocation
of KCC2 to the plasma membrane of MN is reduced after SCI.
REDUCED ACTIVE FORM OF KCC2 IS OBSERVED IN LUMBAR SPINAL
MNs AFTER SCIATIC NERVE CRUSH
In order to mimic the muscle denervation that occurs early
in the ALS progression, we performed a sciatic nerve crush
to analyze early changes of KCC2 after MN axotomy. Results
of western blotting showed a significant decrease of the KCC2
oligomer/monomer ratio and of the phosphorylated active form
of KCC2 in the injured side of the spinal cord in contrast to naïve
animals (Figures 4A,B, p < 0.01). Immunohistochemical label-
ing confirmed that after sciatic nerve crush KCC2was internalized
into the MNs cytoplasm in the injured side forming intracel-
lular clusters. In contrast, KCC2 localization in intact animals,
showed a well-defined line surrounding MNs indicating a prefer-
ably membrane location of KCC2 in non-injured conditions
(Figure 4C).
ABSENCE OF DOWN-REGULATION KCC2 RESPONSE TO AXONAL
INSULT IN ALS MNs
We then studied the KCC2 response in injured MNs, identified by
labeling the activation transcription factor 3 (ATF3) as a marked
of axonal damage (Tsujino et al., 2000), to assess whether KCC2
behave similarly between ALS and axotomized MNs. After sci-
atic nerve crush, KCC2 cytoplasmic inclusions were found into
injured ATF3-positive MNs. On the contrary, the same analy-
sis performed on SOD1G93A ventral spinal cord revealed that
KCC2 localization remained normal even if MNs expressed ATF3
(Figure 5). These results suggest an altered response regarding
KCC2 expression of ALS MNs after muscle denervation.
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FIGURE 2 | Analysis of KCC2 and phopho-KCC2 expression in the
ventral spinal cord of SOD1G93A mice at 8, 12, and 16 weeks of age. (A)
Representative blots of phopho-KCC2 and total KCC2 (on both monomeric
and oligomeric states). (B) KCC2 western blots quantifications. Graphs
represent the ratio between the oligomeric KCC2 (functional state) vs.
monomeric KCC2 and the phopho-KCC2 (active form) vs. monomeric
KCC2. Note the lack of significant differences between SOD1G93A at any
age and wild type littermates. Data are represented as mean ± s.e.m. (C)
Confocal images of wild type and SOD1G93A L4 spinal MNs confirmed the
maintenance of membrane-bound (active) KCC2 in transgenic animals along
disease progression, even in abnormal MNs at 16 weeks of age.
Arrowheads show the membrane bound KCC2 in SOD1G93A L4 spinal
MNs. Scale bar 20µm.
MICROGLIAL REACTIVITY IS INCREASED IN SOD1G93A AND AFTER
SCIATIC NERVE CRUSH AND SCI
It has been reported that microglial cells play a central role in the
pathway that leads to KCC2 dephosphorylation (Coull et al., 2005;
Ferrini et al., 2013). Thus, we evaluated the microglial activation
by immunohistochemistry in SOD1G93A , sciatic nerve crush and
SCI animals. We focused on the L4-L5 lamina IX in order to ana-
lyze the reaction of the microglial cells adjacent to MNs. Results
revealed a progressive increase of microglial immunoreactivity in
SOD1G93A mice from 8 to 16 weeks of age. On the other hand, SCI
and sciatic nerve crush mice also showed an increase in Iba1 reac-
tivity after the lesion at 28 and 7 dpi, respectively. SOD1G93A mice
at 16 weeks of age showed similar levels of Iba1 immunoreactivity
to those observed in nerve crush and SCI mice, when compared
to their respective controls (wild type and naïve) (Figure 6).
INCREASED SEROTONIN PROJECTIONS IN SOD1G93A LUMBAR
SPINAL CORD
Serotonin (5-hydroxytryptamine, 5-HT) has been postulated
as an important factor that contributes to MN excitability by
promoting slight depolarization of their membrane potential
through increased persistent inward currents (Heckman et al.,
2003). 5-HT has been also related to KCC2 phosphorylation
and binding to the cell membrane and the consequent decrease
in spasticity after SCI (Bos et al., 2013). For this reason, we
assessed the 5-HT projections that arrive to L4-L5 spinal MNs.
Immunohistochemical analysis revealed an important increase of
5-HT projections in 16 weeks old SOD1G93A lumbar spinal cord
(Figure 7, p < 0.05).
REDUCED INHIBITION AND RENSHAW CELLS DEGENERATION IN
SOD1G93A LUMBAR SPINAL CORD
Once revealed that KCC2 expression and localization is not
altered along ALS progression, we studied the inhibitory cir-
cuits in the lumbar spinal cord of 16 weeks aged SOD1 animals
to evaluate its potential involvement on hyperreflexia. We ana-
lyzed gephyrin as a general marker of inhibitory glycine and
GABA systems. Results showed a significant decrease of gephyrin
expression in SOD1G93A mice compared to non-transgenic lit-
termates (Figures 8A,B). We also labeled the Renshaw cells in
lamina VII of the L4 spinal cord, since these cells are glycin-
ergic and importantly contribute to the inhibition of MNs. As
described previously (Chang et al., 2009), we found a significant
decrease in the number of calbindin positive cells in 16 weeks
aged SOD1G93A when compared to WT littermates (Figure 8C,
p < 0.05). The findings suggest that inhibition is reduced in
SOD1G93A lumbar spinal cord due to alterations of the glycinergic
system.
DISCUSSION
The results of the present work demonstrate that KCC2 is down-
regulated after peripheral and central nerve injuries. However,
although KCC2 downregulation has been demonstrated to be a
key factor in the appearance of hyperreflexia and spasticity after
such injuries, we did not found changes in the KCC2 dephospho-
rylation that could explain the appearance of spastic behavior at
the late stage (16 weeks of age) of the ALS murine model. On the
other hand, our results suggest that the increased spinal excitabil-
ity and the appearance of spasticity in ALS may be a consequence
of two abnormalities: the loss of inhibitory tone due to loss of
Renshaw glycinergic interneurons, and the increased 5-HT pro-
jections present in the ventral horn that would directly contribute
to increasing MN excitability.
FACTORS CONTRIBUTING TO SPASTICITY IN SOD1G93A MICE
Spasticity is present in ALS patients and leads to disabling com-
plications in hand function and gait (Wijesekera and Leigh,
2009; Kiernan et al., 2011). Several works have investigated the
mechanisms underlying spasticity after traumatic SCI. A relevant
finding of these studies is that KCC2 loss of function is an impor-
tant hallmark of MN increased excitability and thus, of spasticity
after SCI (Boulenguez et al., 2010; Bos et al., 2013). The KCC2
is a potassium-chloride cotransporter, responsible for the low
intracellular chloride concentration that allows GABA and glycine
inhibitory synaptic responses in the adulthood (Rivera et al.,
1999; Ganguly et al., 2001; Wang et al., 2002; Payne et al., 2003;
Stein et al., 2004; Bray and Mynlieff, 2009). Phosphorylation of
S940 in the intracellular C-terminal domain of the KCC2 has
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FIGURE 3 | Confocal images of L4 ventral spinal cord of wild type
and SOD1G93A mice at 8, 12, and 16 weeks of age. Note the
progressive increase in number and volume of abnormal swollen
structures (arrow) along the disease progression in SOD1G93A animals.
The KCC2 remained localized in the cell membrane even in these
swallows (arrowheads). Scale bar 10µm.
been demonstrated to be responsible for the stabilization of KCC2
on the neuronal cell surface, increasing its functional expression
(Li et al., 2007; Lee et al., 2007, 2010). The expression and func-
tion of KCC2 is reduced after neural injuries, participating in the
lowered strength of inhibitory transmission (Coull et al., 2003).
The most prevalent mechanism underlying KCC2 regulation has
been postulated to be mediated by brain-derived neurotrophic
factor (BDNF) released through microglial signaling (Ulmann
et al., 2008; Ferrini and De Koninck, 2013). Indeed, microglia
react to alterations of the extracellular milieu with a protec-
tive and defensive role secreting specific messengers (including
BDNF), that in turn sculpt neuronal circuit excitability (Ferrini
and De Koninck, 2013). Although, this mechanism has been com-
monly described in the dorsal horn of the spinal cord, other
studies also described the microglia-BDNF-TrkB-KCC2 signaling
in the spinal motor system (Ferrini et al., 2013). In agreement,
we found that the decrease of KCC2 phosphorylation after cen-
tral or peripheral nerve injuries in the ventral horn of the spinal
cord was also accompanied by increased microglial reactivity.
Although this phenomenon has been reported to contribute to
spasticity after SCI (Boulenguez et al., 2010; Bos et al., 2013),
here we demonstrate that KCC2 is not altered in SOD1G93A mice
MN, and unlikely contributing to the hyperreflexia and spastic-
ity that occurs in SOD1G93A animals. Our results revealed that,
opposite to what occurs after SCI, KCC2 remained localized in
the cell membrane of MN, even in animals of 16 weeks of age
when hyperreflexia and spasticity are clearly present. Fuchs et al.
(2010) previously reported a down regulation of KCC2 mRNA
in spinal MNs of SOD1G93A mice. They found a slight reduction
of mRNA signal in only a few large MNs of 80 days old animals
(11 weeks of age), despite that almost 50% of lumbar MNs are
not functionally connected to muscle at this time (as evidenced
by the CMAP reduction). When they analyzed KCC2 mRNA at
120 days (17 weeks of age) they found a significant reduction of
mRNA signal area per neuron, although some of the MNs could
be in a degenerative state. KCC2 immunoreactivity was reduced in
the neuropil surrounding MNs, similar to what we observed (see
Figure 3), whereas some MNs bodies had increased KCC2 label-
ing in the cytoplasm (Fuchs et al., 2010). These findings suggest
that KCC2 disregulation is slight and does not occur until very
advanced stages in SOD1G93A mice, quite later than the muscle
denervation process.
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FIGURE 4 | Analysis of KCC2 and phopho-KCC2 expression in the
ventral spinal cord of SCI and sciatic nerve injured mice. (A)
Representative blots of phopho-KCC2 and total KCC2 (on both
monomeric and oligomeric states) in SCI and crush mice. (B) KCC2
western blots quantifications. Graphs represent the ratio between the
oligomeric KCC2 (functional state) vs. monomeric KCC2 and the
phopho-KCC2 (active form) vs. monomeric KCC2. Both analyses
revealed a decrease in the active form of the KCC2 in SCI (28 days
after injury) and in sciatic nerve crush (7 days after injury). Data are
represented as mean ± s.e.m.; ∗p < 0.05, ∗∗p < 0.01 vs. naïve
animals. (C) Confocal images of L4 spinal MNs revealed the presence
of membrane-bound (active) KCC2 in naïve but not in SCI and sciatic
nerve injured animals. Arrowheads point internalized KCC2 aggregates.
Scale bar 20µm.
FIGURE 5 | KCC2 expression and localization in ATF3 labeled
MN in wild type/naïve, sciatic nerve injured and 12 weeks
old SOD1G93A mice. Note that membrane-bound KCC2 is
reduced in ATF3-positive injured neurons after nerve crush, but it
remains in the membrane in ATF3-positive SOD1G93A MNs. Scale
bar 20µm.
Mechanisms underlying spasticity have been mostly studied
in experimental models of SCI. It is considered that SCI associ-
ated spasticity arises from several mechanisms, one of the most
important being alterations of 5-HT inputs to spinal MNs. 5-HT
descending axons from brainstem nuclei densely innervate spinal
MNs, maintaining their excitability through increased persistent
calcium current (Heckman et al., 2003). Although damage of
serotonergic axons caused by a SCI leads to a transient hypoex-
citability of spinal MNs, after a few weeks, MNs compensate
for the loss of serotonin inputs through the overexpression of
5-HT receptors. These synaptic modifications promote hyperex-
citability and consequent spasticity (Murray et al., 2010, 2011). In
accordance, a recent study showed that the heterogeneity of 5-HT
receptors is an important feature of hyperexcitability in MNs
after SCI. Bos et al. (2013) reported that activation of 5-HT2B
and 5-HT2C receptors induced a depolarizing shift in MNs.
However, activation of 5-HT2A participated in the activation and
restoration of KCC2 expression. Our results reveal that MNs of
SOD1G93A mice receive an increased amount of 5-HT projections
at 16 weeks of age. Moreover, in contrast to the localized presence
of 5-HT projections around MNs in WT animals, in SOD1G93A
mice they became spread over lamina IX in the ventral horn of the
spinal cord. As a result, 5-HT labeling was found increased and
could partially explain the hyperreflexia and spasticity observed
at the late stage of the disease, but also the maintenance of KCC2
in the MN membrane. Further studies assessing the differential
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 7 | 7
Mòdol et al. Spasticity and KCC2 in ALS mice
FIGURE 6 | Comparison of microglial (Iba-1 labeled) immunoreactivity in
SOD1G93A , SCI and sciatic nerve injured mice. (A) Representative
confocal images of the ventral part of the lumbar spinal cord of wild
type/naïve, SOD1G93A at 8, 12, and 16 weeks of age, SCI and sciatic nerve
crush injured animals. Scale bar 10µm. (B) Iba-1 immunoreactivity
quantification revealed a progressive increase of microglial reactivity during
disease progression in SOD1G93A mice. At late stages (16 weeks of age),
Iba-1 immunoreactivity level is similar to that observed in SCI and sciatic
nerve injured animals. Values are mean ± s.e.m. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001 vs. respective wild type/naïve animals.
FIGURE 7 | Serotonin (5-HT) projections to MN pools in the lumbar spinal
cord of 16 weeks old SOD1G93A mice and wild type littermates. (A)
Respresentative confocal images show increased 5-HT projections in
SOD1G93A compared to wild type mice. Scale bar 20µm. (B) Quantification of
the immunolabeling shows a 2 fold increase of 5-HT labeled area in SOD1G93A
animals at 16 weeks of age. Values are mean ± s.e.m. ∗p < 0.05 vs. wild type.
expression of 5-HT receptors in SOD1G93A mice would be of
interest for understanding their interaction with the KCC2 role
in ALS.
We further assessed the inhibitory state of the lumbar
spinal cord by measuring gephyrin expression. Gephyrin is a
structural component of the postsynaptic protein network of
both glycine and GABA inhibitory synapses in the spinal cord
(Bohlhalter et al., 1994). Our results show a significant reduc-
tion of gephyrin expression in 16 weeks old SOD1G93A ani-
mals, evidencing decreased inhibition in the ventral spinal cord.
Since gephyrin participates in glycine receptor clustering but
not in GABAergic synapses formation (Lévi et al., 2004), we
further investigated the glycinergic Renshaw cells at late stages
in SOD1 mice. Renshaw cells are spinal interneurons located
in the ventral horn gray matter that mediate recurrent inhibi-
tion to spinal MNs (Katz and Pierrot-Deseilligny, 1999; Alvarez
and Fyffe, 2007). These cells have been related to spasticity
(Mazzocchio and Rossi, 1997) and, recently, postulated as con-
tributors to spasticity in ALS (Mazzocchio and Rossi, 2010).
In fact, our results revealed a significant decrease in the num-
ber of calbindin labeled Renshaw cells in the lumbar spinal
cord of SOD1 mice at 16 weeks of age. The loss of inhibitory
interneurons could partially explain the abnormally increased
spinal excitability found in SOD1G93A animals at late stages.
Indeed, Chang and Martin have reported an early presymp-
tomatic loss of glycinergic synaptic buttons onto MNs (Chang
and Martin, 2009) and the abnormal properties of glyciner-
gic channels in dissociated G93A MNs (Chang and Martin,
2011).
Taken together, our results suggest two distinct mechanisms
that may be contributing to hyperreflexia and increased spinal
excitability in the SOD1 mouse model. On the one hand,
increased lumbar 5-HT may enhance MN excitability through
the activation of 5-HT2B and 5-HT2C receptors and, on the
other hand, the loss of Renshaw cell leads to a reduction in
inhibitory inputs onto MNs. Both phenomena may explain the
disabling spastic paresis observed in SOD1G93A animals at the
late stage. These exogenous influences may add to the mild MN
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 7 | 8
Mòdol et al. Spasticity and KCC2 in ALS mice
FIGURE 8 | Evaluation of inhibitory intraspinal circuits in SOD1G93A
mice at 16 weeks of age. (A) Representative blots and quantification of
gephyrin expression in the ventral part of the lumbar spinal cord. Results
revealed that gephyrin expression in 16 weeks old SOD1 mice was reduced
when compared to wild type mice. (B) Number of Renshaw cells in the
ventral horn of L4 spinal cord of wild type and SOD1G93A animals at 16
weeks of age. Values are mean ± s.e.m. ∗∗p < 0.01 vs. wild type animals.
(C) Representative confocal images of Renshaw cells in the L4 spinal cord
of wild type and 16 weeks old SOD1G93A animals. Scale bar 10µm.
depolarization state described in this ALS murine model (Boërio
et al., 2010).
DIFFERENTIAL MN RESPONSE BETWEEN SOD1G93A AND
NERVE CRUSHED MNs
Once demonstrated the lack of KCC2 downregulation in
SOD1G93A MNs when compared to SCI, we explored whether
the KCC2 response could be an intrinsic feature of ALS MNs. To
test this hypothesis, we compared the differences in KCC2 expres-
sion between ALS and axotomized wild type MNs. Our results
demonstrate for the first time that KCC2 down regulation also
occurs in spinal MNs after peripheral nerve injury, as showed
by the decrease in the active pKCC2 after sciatic nerve crush.
Immunohistochemical evaluation also revealed that MNs labeled
for ATF3, a typical marker of axonal injury (Tsujino et al., 2000;
Navarro et al., 2007), presented an evident translocation of KCC2
from the plasma membrane to cytoplasmic aggregates. This fact
indicates that injured MNs were actively down regulating KCC2
from their cell membrane. After lesion of peripheral axons, dif-
ferential regulation of protein expression occurs and plays a role
in transitioning the neuron from a transmission mode to a regen-
erative, growth mode (Fu and Gordon, 1997; Pieraut et al., 2007,
2011). One example of the plastic changes that occur after axo-
tomy, are the excitatory responses to GABA and glycine induced
by the loss of KCC2 in the neuronal cell membrane. This shift in
the balance between excitatory and inhibitory influences that ren-
ders injured networks hyperexcitable has been implicated in the
pathogenesis of neuropathic pain in dorsal horn neurons (Coull
et al., 2003; Cramer et al., 2008; Hasbargen et al., 2010; Janssen
et al., 2011, 2012).
Our results in SOD1G93A mice revealed that KCC2 remained
in its active phosphorylated form and located in the cell mem-
brane even in MNs that highly expressed ATF3, evidencing a
recent process of target muscle disconnection (Vlug et al., 2005;
Saxena et al., 2009). After axotomy, KCC2 loss of function would
contribute to an increase of spinal synaptic excitability and hyper-
reflexia (Valero-Cabré and Navarro, 2001), as a feature of the
plastic changes that may play a role on nerve regeneration and
functional recovery. The lack of such changes in ALS MNs could
suggest an inability of these cells to initiate some cellular events
in response to muscle disconnection that would allow for axonal
regeneration and re-establishment of new neuromuscular junc-
tions. The abnormal response to insults would be also manifested
by a progressive increase of neurofilament aggregates (Julien,
1997) surrounded by active and phosphorylated KCC2with age in
SOD1G93A MNs. This observation could explain the fact that we
did not observe any changes in the KCC2 activity by analyzing the
WB result when comparing with wild type animals. Nevertheless,
despite the active KCC2 downregulation could be likely due to
muscle disconnection per se, it cannot be discarded that such
changes are produced by transynaptic effects of the injured pri-
mary sensory afferents, explaining the differences we observed
between ALS and nerve crushed mice. Thus, further experi-
ments are needed to understand whichmechanisms underline the
reduction of KCC2 activity.
In summary, the present results demonstrate that there is not
downregulation of KCC2 expression from the plasma membrane
of ALS MNs, even at advanced stage of the disease, when they
have suffered deafferentation from upper MNs and axonal dam-
age and muscle disconnection. This is in contrast to what we
found after either SCI or peripheral nerve injury, which induced
a rapid decrease of KCC2 phosphorylation in MNs. Such a KCC2
change has been previously described in spinal MNs linked to the
development of spasticity (Boulenguez et al., 2010), and in dor-
sal horn neurons related to the appearance of neuropathic pain
(Janssen et al., 2012). The fact that KCC2 is not downregulated
along the lifespan of SOD1 mice could indicate that ALS MNs do
not react as axotomized normal MNs after muscle denervation.
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